Post-menopausal Women Osteoporosis(Phase III)

NCT01806792 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Postmenopausal Women Osteoporosis

Interventions

DRUG: risedronate combine
DRUG: Risedronate
DRUG: Placebo(for Risedronate)
DRUG: Placebo(for risedronate combine)

Sponsor

Hanlim Pharm. Co., Ltd.